Search

everythinglearnresearchcommunity

for

Search:↓

Adding soybean oil to Nonomuraea dietziae increases production of a beneficial compound by improving metabolism and enzyme systems.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

Fermentation of Finasteride with Ocimum sanctum L. creates new metabolite that inhibits tyrosinase.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Confirming low-dose endocrine toxicities is difficult and requires more research.

OM-X® helped prevent negative effects of Vitamin C deficiency in mice, suggesting it could protect organs and regulate metabolism.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.

Sebocytes play a key role in controlling androgen levels in human skin.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Efficient enzyme function relies on specific residue interactions and structural coordination.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

New genes and pathways are important for testosterone production and male sexual development.

Tunable structured metal oxides show promise for various medical treatments due to their versatility and cost-effectiveness.

Glioblastoma cells can make androgens, which might help the tumor grow.

5α-reductases increase epitestosterone's effect on androgen receptors.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Researchers developed a method to identify and analyze cyclosporin compounds and their structures effectively.

The document's conclusion cannot be provided because the document is not available or cannot be read.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.